MIRAVANT MEDICAL TECHNOLOGIES
11-K, 1999-07-14
PHARMACEUTICAL PREPARATIONS
Previous: GENERAL MAGIC INC, S-3/A, 1999-07-14
Next: BROOKS AUTOMATION INC, 8-K, 1999-07-14




                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 11-K
                 ANNUAL REPORT PURSUANT TO SECTION 15 (d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

|X|      ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES
         EXCHANGE ACT OF 1934

                      For the year ended December 31, 1998

                                       OR
|_|      TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE
         SECURITIES EXCHANGE ACT OF 1934 [NO FEE REQUIRED]

                         Commission File Number: 0-25544

                                 ---------------


A.   Full title of the plan and the address of the plan, if different  from that
     of the issuer named below:

       Miravant Medical Technologies 401(k)-Employee Stock Ownership Plan

B.   Name of the  issuer of the  securities  held  pursuant  to the plan and the
     address of its principal executive office:

                          Miravant Medical Technologies
                336 Bollay Drive, Santa Barbara, California 93117

                                    SIGNATURE

Pursuant to the  requirements of the Securities  Exchange Act of 1934,  Miravant
Medical Technologies as Plan Administrator has duly caused this annual report to
be signed on its behalf by the undersigned thereunto duly authorized.

                    Miravant   Medical   Technologies    401(k)-Employee   Stock
                    Ownership Plan

                    By: /s/ John M. Philpott
                    -------------------------
                            John M.  Philpott
                            Chief  Financial Officer

Dated:   July 14, 1999




       Miravant Medical Technologies 401(k)-Employee Stock Ownership Plan



<TABLE>
<CAPTION>
<S>                                                                                                                <C>

Financial Statements:
   Report of Independent Auditors..................................................................................3
   Statements of Net Assets Available for Benefits as of December 31, 1998 and 1997................................4
   Statement of Changes in Net Assets Available for Benefits for the year ended December 31, 1998..................5
   Notes to Financial Statements...................................................................................6

Supplemental Schedules:
   Item 27 (a) - Schedule of Assets Held for Investment Purposes..................................................10
   Item 27 (d) - Schedule of Reportable Transactions..............................................................11



</TABLE>

                         Report of Independent Auditors


Plan Administrator
Miravant Medical Technologies
  401(k)-Employee Stock Ownership Plan

We have audited the accompanying statements of net assets available for benefits
of the Miravant Medical Technologies  401(k)-Employee Stock Ownership Plan as of
December  31, 1998 and 1997 and the related  statement  of changes in net assets
available  for benefits for the year ended  December 31, 1998.  These  financial
statements are the responsibility of the Plan's  management.  Our responsibility
is to express an opinion on these financial statements based on our audits.

We  conducted  our  audits  in  accordance  with  generally   accepted  auditing
standards.  Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement.  An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements.  An audit also includes
assessing  accounting   principles  used  and  significant   estimates  made  by
management,  as well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.

In our opinion,  the financial  statements  referred to above present fairly, in
all material  respects,  the net assets  available  for benefits of the Miravant
Medical Technologies  401(k)-Employee  Stock Ownership Plan at December 31, 1998
and 1997, and the changes in its net assets  available for benefits for the year
ended  December  31,  1998 in  conformity  with  generally  accepted  accounting
principles.

Our audit was  performed  for the purpose of forming an opinion on the financial
statements taken as a whole. The accompanying  supplemental  schedules of assets
held for investment purposes as of December 31, 1998 and reportable transactions
for the year then ended,  are presented for purposes of additional  analysis and
are  not a  required  part of the  financial  statements  but are  supplementary
information  required by the  Department  of Labor's Rules and  Regulations  for
Reporting and Disclosure  under the Employee  Retirement  Income Security Act of
1974. The supplemental  schedules have been subjected to the auditing procedures
applied in our audit of the financial statements and, in our opinion, are fairly
stated in all material respects in relation to the financial statements taken as
a whole.

                                                     /s/ ERNST & YOUNG LLP
                                                     ---------------------
                                                         ERNST & YOUNG LLP

Woodland Hills, CA
July 9, 1999




                          Miravant Medical Technologies
                      401(k)-Employee Stock Ownership Plan
                 Statements of Net Assets Available for Benefits

<TABLE>
<CAPTION>
<S>                                                                        <C>                           <C>


                                                                                            December 31,

                                                                                    1998                  1997
                                                                                    ----                  ----
Assets:
   Employer contribution receivable..........................................      $  23,500             $   6,880
   Participant contribution receivable.......................................          3,660                 2,130
Investments, At Fair Value:
   Short-term investments....................................................          1,450                 1,870
   Miravant Medical Technologies common stock at fair value (at a
      cost of $111,560 and $32,670 for the years ended December 31,
      1998 and 1997, respectively)...........................................         71,840                28,840
                                                                           ------------------    ------------------
Total assets.................................................................        100,450                39,720

Liabilities:
   Unsettled trade...........................................................          1,360                 1,930
                                                                           ------------------    ------------------
Total liabilities............................................................          1,360                 1,930

Net assets available for benefits............................................      $  99,090             $  37,790
                                                                           ==================    ==================


</TABLE>









See accompanying notes.



                          Miravant Medical Technologies
                      401(k)-Employee Stock Ownership Plan
            Statement of Changes in Net Assets Available for Benefits
                          Year Ended December 31, 1998

<TABLE>
<CAPTION>
<S>                                                                                       <C>


Additions to net assets attributed to:
  Participant contributions.....................................................          $  70,470
  Employer matching contributions...............................................             35,060
  Investment income(loss):
    Interest income.............................................................                 30
    Net realized and unrealized depreciation in fair value of investments.......            (37,510)
                                                                                      ------------------

Total additions.................................................................             68,050

Deductions to net assets attributed to:
   Benefit payments to participants.............................................              6,630
   Administrative expenses......................................................                120
                                                                                      ------------------
Total deductions................................................................              6,750

Net increase....................................................................             61,300

Net assets available for benefits:
   Beginning of the year........................................................             37,790
                                                                                      ------------------

   End of the year..............................................................          $  99,090
                                                                                      ==================


</TABLE>





See accompanying notes.




       Miravant Medical Technologies 401(k)-Employee Stock Ownership Plan
                          Notes to Financial Statements
                                December 31, 1998

1.   Plan Description

     The Miravant Medical Technologies 401(k)-Employee Stock Ownership Plan (the
     "Plan") was  established to assist eligible  employees of Miravant  Medical
     Technologies  (the  "Company") to acquire and  accumulate  shares of common
     stock  of the  Company  through  payroll  deductions.  The  following  plan
     description provides only summary information;  reference should be made to
     the Plan document for more complete information.

     Substantially  all employees of the Company having at least three months of
     employment  with the Company (as defined in the Plan document) are eligible
     to participate in the Plan. The Plan provides that  participants  may elect
     to contribute from 1% to 6% of their  compensation up to the maximum limits
     permitted by the Internal  Revenue Code (the "Code").  The Code also places
     limits on the total  amount which can be added to any  employee's  accounts
     for a given year which apply in aggregate to all retirement plans sponsored
     by the Company.

     Under the provisions of the Plan, participant contributions are invested by
     the trustee in the  Company's  common  stock no later than the close of the
     third business day following the receipt of the participants' contributions
     from the Company. Upon receipt of the participant contributions,  but prior
     to the investment in the Company's  common stock, the funds are temporarily
     invested  by  the  trustee  in  short-term  investments  or  U.S.  Treasury
     obligations.

     Participants  in the  Plan  become  eligible  for a  discretionary  Company
     matching contribution  immediately upon enrolling in the Plan. All matching
     contributions  are invested in the Company's  common stock and the matching
     contribution  percentage  for each plan year is determined by the Company's
     Board of  Directors  prior to the  start of the Plan  year.  The  Company's
     matching  contributions  are made on a quarterly  basis,  and may be in the
     form of cash, shares of the Company's common stock, any other assets or any
     combination  thereof.  The employer's matching  contribution in the form of
     common stock is  determined  by using the closing  market price on the last
     business day of each quarter.  Matching cash  contributions are invested by
     the trustee in the  Company's  common stock within three  business  days of
     receipt of the cash contribution.  For the year ended December 31, 1998 the
     Board of Directors  directed the Company to contribute  half of the amounts
     contributed  by the  participants.  The amounts  contributed by the Company
     during 1998 were made in the form of the Company's common stock and cash.

     Participants  become fully vested in the portion of the Company's  matching
     contributions  allocated  to their  accounts  if they are  employed  by the
     Company immediately prior to the following:  a) retirement (on or after the
     age of 59 1/2), b) permanent disability, c) death, or d) after a designated
     time period according to the following vesting schedule:

               Years of Service                   Vested Percentage
               ----------------                   -----------------

               Less than two years                      0%
               Two years                               10%
               Three  years                            30%
               Four  years                             60%
               Five or more years                     100%

     If a participant leaves the Company prior to retirement, the portion of his
     or her matching account which is not vested will be forfeited.  Forfeitures
     are divided among the accounts of the remaining  participants in accordance
     with  specific  conditions  defined in the Plan.  The Plan also  contains a
     rehire provision whereby if a participant leaves the Company and is rehired
     before being separated from service for five years,  the forfeited  portion
     of the participants account will be restored.  The forfeitures  reallocated
     for the year ended December 31, 1998 were $3,702.

     Common stock,  plus cash for any partial share credited to a  participant's
     account,   will  be  generally  distributed  to  the  participant  (or  the
     participant's  designated  beneficiary  or estate) in full,  within certain
     limitations  and  restrictions  as provided by the Plan document,  no later
     than 60 days  after the end of the Plan  year  during  which a  participant
     becomes  eligible for a distribution  due to permanent  disability,  death,
     retirement  or  termination   of   employment.   Prior  to  termination  of
     employment,  shares can be distributed to a participant  upon attaining age
     59 1/2 while still an employee or for  emergencies at the discretion of the
     Stock Purchase Plan Committee, as provided in the Plan document.

     The Plan's assets, which consist principally of the Company's common stock,
     are held in safekeeping for custodial  purposes by an independent  trustee.
     Contributions  are managed by the trustee,  which invests cash received and
     interest,  and makes distributions to participants.  Certain administrative
     functions  are  performed by officers or employees of the Company.  No such
     officer or employee receives compensation from the Plan.

     The Company  currently  expects to continue  the Plan  indefinitely  and to
     continue  to make  contributions  under  the  Plan.  However,  there  is no
     contractual  commitment  requiring  the  Company to  continue to make these
     contributions  to the Plan. The Company's  Board of Directors has the right
     to alter or terminate  the Plan at any time and for any reason,  subject to
     the  provisions  of the  Employee  Retirement  Income  Security Act of 1974
     ("ERISA").  In the event of Plan termination,  participants will become 100
     percent vested in their accounts.

2.   Summary of Significant Accounting Policies

     Basis of Accounting

     The accompanying  financial statements are prepared on the accrual basis of
     accounting.

     Estimates and Assumptions

     The  preparation  of financial  statements  in  conformity  with  generally
     accepted  accounting  principles  requires management to make estimates and
     assumptions  that affect the amounts  reported in the financial  statements
     and  the  accompanying  notes.  Actual  results  could  differ  from  those
     estimates and such differences may be material to the financial statements.

     Participant Contributions

     Contributions  are recorded when the Company makes payroll  deductions from
     the Plan participants.

     Participant Withdrawals

     Participant  withdrawals and payments made to terminated  participants  are
     recorded on the date distributions are made.

     Stock Purchases

     Stock  purchases  are made by the Plan's  Trustee by the close of the third
     business day following  receipt of the participant  contributions  from the
     Company.

     Investment Valuation

     The Plan's  investments are stated at fair value.  The closing market share
     price as of December  31 is used to value  shares of the  Company's  common
     stock.

     Plan Expenses

     Substantially all of the plan expenses are paid for by the Company.

3.   Income Tax Status

     The Plan has applied for but has not yet  received a  determination  letter
     from the Internal  Revenue Service stating that the Plan is qualified under
     Section 401(a) of the Code. However,  the Plan Administrator  believes that
     the Plan is  qualified  and,  therefore,  the related  trust is exempt from
     taxation.

4.   Administrative Expenses

     Certain administrative  functions are performed by officers or employees of
     the Company.  No officers or employees receive  compensation from the Plan.
     Substantially  all expenses  associated with  establishment,  operation and
     administration of the Plan are paid by the Company.

5.   Party-In-Interest Transactions

     The Company and the trustee  are  parties-in-interest  with  respect to the
     Plan under the  provisions  of ERISA.  The records of the Plan  indicate no
     party-in-interest  transactions  which are  prohibited by ERISA Section 406
     and for which no statutory or administrative exemption exists.

6.   Differences Between Financial Statements and Form 5500

     Amounts  allocated to withdrawn  participants are recorded on the Form 5500
     for benefit  claims that have been processed and approved for payment prior
     to year end but not yet paid. As such, Net Assets Available for Benefits of
     the financial  statements differ from Net Assets Available for Benefits per
     the  Form  5500  by  $4,170  due  to the  amounts  allocated  to  withdrawn
     participants.  There were no such  differences  at December  31,  1997.  In
     addition,  benefits paid per the financial  statements differ from benefits
     paid per the Form 5500 by $4,170 due to the amounts  allocated to withdrawn
     participants.

7.   Year 2000 Issue (Unaudited)

     The record  keeping and trustee  function  of the Plan are  performed  by a
     third-party service provider.  In addition,  the Company's payroll function
     which  supplies data in support of these  functions is also  performed by a
     third-party  service  provider.  These service providers have been actively
     addressing  the impact of the Year 2000 issue on their  ability to continue
     to provide their services to the Plan and are  implementing  any corrective
     actions  necessary to insure that their systems will function properly with
     respect to dates in the Year 2000,  and,  thereafter.  The Company does not
     believe,  based on indications from these  third-party  service  providers,
     that the Year  2000  issue  will  pose  significant  operational  or record
     keeping problems for the Plan.



       Miravant Medical Technologies 401(k)-Employee Stock Ownership Plan
          Item 27(a) - Schedule of Assets Held for Investment Purposes*
                                December 31, 1998

<TABLE>
<CAPTION>
<S>                                                                              <C>              <C>

                                                                                                      Current
            Identity of Issue              Description of Asset                      Cost              Value
- ------------------------------------------ ------------------------------------ ---------------- -----------------
     Miravant Medical Technologies**       Common Stock (5,580 shares)              $ 111,560         $  71,840


</TABLE>


*    Under ERISA, an asset held for investment purposes is any asset held by the
     Plan on the last day of the  Plan's  fiscal  year or  acquired  at any time
     during the Plan's  fiscal year and  disposed of at any time before the last
     day of the Plan's fiscal year, with certain exceptions.

**   Party-In-Interest



       Miravant Medical Technologies 401(k)-Employee Stock Ownership Plan
                 Item 27(d)-Schedule of Reportable Transactions*
                          Year Ended December 31, 1998

<TABLE>
<CAPTION>
<S>                                                                             <C>           <C>                <C>

                                                                                              Current Value of
   Identity of Party                                    Purchase     Selling      Cost of          Asset on      Net Gain/(Loss)
       Involved             Description of Assets         Price        Price       Asset      Transaction Date
- ------------------------ ---------------------------- -------------- ----------- ----------- ------------------ --------------
   Miravant Medical
    Technologies**       Common Stock
                         (Purchased 4,971 shares)           $80,660          --    $ 80,660            $80,660           --
                         (Sold 60 shares)                        --     $ 2,730     $ 4,350            $ 2,730      ($ 1,620)

     Sanwa Bank**        Short-term investments
                                                           $ 79,890          --    $ 79,890           $ 79,890           --
                                                                 --    $ 80,310    $ 80,310           $ 80,310           --


</TABLE>


*    Transactions  in excess of five percent of the current  value of the Plan's
     assets as of  January  1, 1998 as  defined  in  Section  2520.103-6  of the
     Department of Labor's Rules and  Regulations  for Reporting and  Disclosure
     under ERISA.

**   Party-In-Interest



                                INDEX TO EXHIBITS

Exhibit                                                  Incorporating Reference
Number                Description                              (If Applicable)

23.1                  Consent of Independent Auditors








                                  EXHIBIT 23.1
                         CONSENT OF INDEPENDENT AUDITORS

We consent to the incorporation by reference in the Registration Statement (Form
S-8  No.   333-34953)   pertaining   to  the   Miravant   Medical   Technologies
401(k)-Employee  Stock  Ownership  Plan of our report  dated July 9, 1999,  with
respect to the  financial  statements  and  schedules  of the  Miravant  Medical
Technologies 401(k)-Employee Stock Ownership Plan included in this Annual Report
(Form 11-K) for the year ended December 31, 1998.


                           /s/  ERNST & YOUNG LLP
                           ----------------------
                                ERNST & YOUNG LLP



Woodland Hills, California
July 13, 1999



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission